202 related articles for article (PubMed ID: 22159698)
1. Inhibition of heme oxygenase-1 partially reverses the arsenite-mediated decrease of CYP1A1, CYP1A2, CYP3A23, and CYP3A2 catalytic activity in isolated rat hepatocytes.
Anwar-Mohamed A; Klotz LO; El-Kadi AO
Drug Metab Dispos; 2012 Mar; 40(3):504-14. PubMed ID: 22159698
[TBL] [Abstract][Full Text] [Related]
2. Effect of arsenite on induction of CYP1A, CYP2B, and CYP3A in primary cultures of rat hepatocytes.
Jacobs JM; Nichols CE; Andrew AS; Marek DE; Wood SG; Sinclair PR; Wrighton SA; Kostrubsky VE; Sinclair JF
Toxicol Appl Pharmacol; 1999 May; 157(1):51-9. PubMed ID: 10329507
[TBL] [Abstract][Full Text] [Related]
3. Arsenite down-regulates cytochrome P450 1A1 at the transcriptional and posttranslational levels in human HepG2 cells.
Anwar-Mohamed A; El-Kadi AO
Free Radic Biol Med; 2010 May; 48(10):1399-409. PubMed ID: 20188822
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of cytochrome P450 1a1 by arsenite in vivo and in vitro in C57BL/6 mice.
Anwar-Mohamed A; Abdelhamid G; Amara IE; El-Kadi AO
Free Radic Biol Med; 2013 May; 58():52-63. PubMed ID: 23369756
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase.
Korashy HM; El-Kadi AO
Toxicology; 2012 Jan; 291(1-3):113-21. PubMed ID: 22120038
[TBL] [Abstract][Full Text] [Related]
6. Modulation of cytochrome P450 1 (Cyp1) by vanadium in hepatic tissue and isolated hepatocyte of C57BL/6 mice.
Abdelhamid G; Amara IE; Anwar-Mohamed A; El-Kadi AO
Arch Toxicol; 2013 Aug; 87(8):1531-43. PubMed ID: 23423713
[TBL] [Abstract][Full Text] [Related]
7. Strain differences in hepatic cytochrome P450 1A and 3A expression between Sprague-Dawley and Wistar rats.
Kishida T; Muto S; Hayashi M; Tsutsui M; Tanaka S; Murakami M; Kuroda J
J Toxicol Sci; 2008 Oct; 33(4):447-57. PubMed ID: 18827444
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of cytochrome P450 1A1 by monomethylarsonous acid in human HepG2 cells.
Elshenawy OH; Abdelhamid G; Soshilov AA; Denison MS; El-Kadi AO
Toxicol Lett; 2017 Mar; 270():34-50. PubMed ID: 28189647
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone controls aryl hydrocarbon receptor (AhR)-mediated CYP1A1 and CYP1A2 expression and activity in primary cultures of human hepatocytes.
Vrzal R; Stejskalova L; Monostory K; Maurel P; Bachleda P; Pavek P; Dvorak Z
Chem Biol Interact; 2009 May; 179(2-3):288-96. PubMed ID: 19022236
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of arsenite-mediated decreases in CYP3A23 in rat hepatocytes.
Noreault TL; Jacobs JM; Nichols RC; Trask HW; Wrighton SA; Sinclair PR; Sinclair JF
Biochem Biophys Res Commun; 2005 Aug; 333(4):1211-7. PubMed ID: 15979568
[TBL] [Abstract][Full Text] [Related]
11. Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes.
Nishimura M; Koeda A; Suganuma Y; Suzuki E; Shimizu T; Nakayama M; Satoh T; Narimatsu S; Naito S
Drug Metab Pharmacokinet; 2007 Jun; 22(3):178-86. PubMed ID: 17603218
[TBL] [Abstract][Full Text] [Related]
12. Modulation of aryl hydrocarbon receptor-regulated enzymes by trimethylarsine oxide in C57BL/6 mice: In vivo and in vitro studies.
Elshenawy OH; El-Kadi AO
Toxicol Lett; 2015 Oct; 238(1):17-31. PubMed ID: 26144063
[TBL] [Abstract][Full Text] [Related]
13. Effect of arsenite on induction of CYP1A and CYP2H in primary cultures of chick hepatocytes.
Jacobs J; Roussel R; Roberts M; Marek D; Wood S; Walton H; Dwyer B; Sinclair P; Sinclair J
Toxicol Appl Pharmacol; 1998 Jun; 150(2):376-82. PubMed ID: 9653069
[TBL] [Abstract][Full Text] [Related]
14. MG-132 inhibits the TCDD-mediated induction of Cyp1a1 at the catalytic activity but not the mRNA or protein levels in Hepa 1c1c7 cells.
Anwar-Mohamed A; Elbekai RH; El-Kadi AO
Toxicol Lett; 2008 Nov; 182(1-3):121-6. PubMed ID: 18835339
[TBL] [Abstract][Full Text] [Related]
15. Mercury modulates the CYP1A1 at transcriptional and posttranslational levels in human hepatoma HepG2 cells.
Amara IE; Anwar-Mohamed A; El-Kadi AO
Toxicol Lett; 2010 Dec; 199(3):225-33. PubMed ID: 20837117
[TBL] [Abstract][Full Text] [Related]
16. Regulatory mechanisms modulating the expression of cytochrome P450 1A1 gene by heavy metals.
Korashy HM; El-Kadi AO
Toxicol Sci; 2005 Nov; 88(1):39-51. PubMed ID: 16093525
[TBL] [Abstract][Full Text] [Related]
17. TSU-16, (Z)-3-[(2,4-dimethylpyrrol-5-yl)methylidenyl]-2-indolinone, is a potent activator of aryl hydrocarbon receptor and increases CYP1A1 and CYP1A2 expression in human hepatocytes.
Matsuoka-Kawano K; Yoshinari K; Nagayama S; Yamazoe Y
Chem Biol Interact; 2010 Apr; 185(1):33-41. PubMed ID: 20171196
[TBL] [Abstract][Full Text] [Related]
18. Activation of the aryl hydrocarbon receptor decreases rifampicin-induced CYP3A4 expression in primary human hepatocytes and HepaRG.
Rasmussen MK; Daujat-Chavanieu M; Gerbal-Chaloin S
Toxicol Lett; 2017 Aug; 277():1-8. PubMed ID: 28571685
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2.
Rhodes SP; Otten JN; Hingorani GP; Hartley DP; Franklin RB
J Pharmacol Toxicol Methods; 2011; 63(3):223-6. PubMed ID: 21111054
[TBL] [Abstract][Full Text] [Related]
20. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on heme oxygenase-1, biliverdin IXalpha reductase and delta-aminolevulinic acid synthetase 1 in rats with wild-type or variant AH receptor.
Niittynen M; Tuomisto JT; Pohjanvirta R
Toxicology; 2008 Sep; 250(2-3):132-42. PubMed ID: 18657588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
